1,233
Views
12
CrossRef citations to date
0
Altmetric
Review

Advances in spirometry testing for lung function analysis

ORCID Icon
Pages 559-569 | Received 20 Feb 2019, Accepted 10 Apr 2019, Published online: 23 Apr 2019

References

  • Valentinuzzi ME, Johnston R. Spirometry: a historical gallery up to 1905. IEEE Pulse. 2014;5(1):73–76.
  • Lopes AJ, de Melo PL. Brazilian studies on pulmonary function in COPD patients: what are the gaps? Int J Chron Obstruct Pulmon Dis. 2016;11:1553–1567.
  • Heffler E, Crimi C, Mancuso S, et al. Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients. Respir Med. 2018;142:48–52.
  • Sokol KC, Sharma G, Lin YL, et al. Choosing wisely: adherence by physicians to recommended use of spirometry in the diagnosis and management of adult asthma. Am J Med. 2015;128(5):502–508.
  • Pothirat C, Chaiwong W, Phetsuk N. Quality assurance of spirometry for COPD clinic accreditation in Thailand. J Med Assoc Thai. 2016;99(11):1167–1172.
  • Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116(2):416–423.
  • Pothirat C, Chaiwong W, Phetsuk N, et al. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study. Int J Chron Obstruct Pulmon Dis. 2015;10:535–540.
  • Aggarwal AN, Gupta D, Agarwal R, et al. Comparison of lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice. Respir Care. 2011;56(11):1778–1784.
  • Redlich CA, Tarlo SM, Hankinson JL, et al. Official American thoracic society technical standards: spirometry in the occupational setting. Am J Respir Crit Care Med. 2014;189(8):983–993.
  • García-Río F, Calle M, Burgos F, et al. Spirometry. spanish society of pulmonology and thoracic surgery (SEPAR). Arch Bronconeumol. 2013;49(9):388–401.
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968.
  • Bhatt SP, Bhakta NR, Wilson CG, et al. New spirometry indices for detecting mild airflow obstruction. Sci Rep. 2018;8(1):17484.
  • Piorunek T, Kostrzewska M, Stelmach-Mardas M, et al. Small airway obstruction in chronic obstructive pulmonary disease: potential parameters for early detection. Adv Exp Med Biol. 2017;980:75–82.
  • Culver BH, Graham BL, Coates AL, et al. Recommendations for a standardized pulmonary function report. An official American thoracic society technical statement. Am J Respir Crit Care Med. 2017;196(11):1463–1472.
  • Lukic KZ, Coates AL. Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma? Pediatr Pulmonol. 2015;50(9):863–868.
  • Dilektasli AG, Porszasz J, Casaburi R, et al. A novel spirometric measure identifies mild COPD unidentified by standard criteria. Chest. 2016;150(5):1080–1090.
  • Bhattarai B, Ghosh M, Sinha A, et al. Can the FEV3/FVC ratio be reliably used to screen for lung injury in the absence of obstruction in African American population?. Presented at: American Thoracic Society 2014 International Conference. San Diego, CA; 2014 16–21 May.
  • Su ZQ, Guan WJ, Li SY, et al. Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3031–3044.
  • Ng SC, Abu Samah F, Helmy K, et al. Comparison between FEV1/FEV6 and FEV1/FVC as screening of chronic obstructive pulmonary disease. Med J Malaysia. 2017;72(5):286–290.
  • Chung KS, Jung JY, Park MS, et al. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population. Int J Chron Obstruct Pulmon Dis. 2016;11:1957–1963.
  • Wang S, Gong W, Tian Y, et al. FEV1/FEV6 in primary care is a reliable and easy method for the diagnosis of COPD. Respir Care. 2016;61(3):349–353.
  • Nève V, Hulo S, Edmé JL, et al. Utility of measuring FEV0.75/FVC ratio in preschoolers with uncontrolled wheezing disorder. Eur Respir J. 2016;48(2):420–427.
  • Chawes BL. Low-grade disease activity in early life precedes childhood asthma and allergy. Dan Med J. 2016;63(8):B5272.
  • Quanjer PH, Weiner DJ, Pretto JJ, et al. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051–1058.
  • Nambu A, Zach J, Schroeder J, et al. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol. 2016;85(11):2144–2151.
  • American Thoracic Society. Lung Function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202–1218.
  • Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117–1122.
  • Martinez L, Rodrigues D, Donária L, et al. Difference between slow and forced vital capacity and its relationship with dynamic hyperinflation in patients with chronic obstructive pulmonary disease. Lung. 2019. [Epub ahead of print].
  • Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–1821.
  • Dominelli PB, Foster GE, Guenette JA, et al. Quantifying the shape of the maximal expiratory flow-volume curve in mild COPD. Respir Physiol Neurobiol. 2015;219:30–35.
  • Wang W, Xie M, Dou S, et al. Computer quantification of “angle of collapse” on maximum expiratory flow volume curve for diagnosing asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:3015–3022.
  • Belo J, Palmeiro T, Caires I, et al. Reference values for spirometry in elderly individuals: a cross-sectional study of different reference equations. Multidiscip Respir Med. 2018;13:4.
  • Sriram KB, Fountain Z, Hockenhull J, et al. Evaluating the appropriateness of hospital doctors‘ requests for pulmonary function tests beyond basic spirometry: results from a prospective observational study. Hosp Pract. 2017;45(3):118–122.
  • Quanjer PH, Pretto JJ, Brazzale DJ, et al. Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J. 2014;43(2):505–512.
  • Culver B. Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies. Eur Respir J. 2015;46(1):8–10.
  • Ketfi A, Gharnaout M, Bougrida M, et al. The multi-ethnic global lung initiative 2012 (GLI-2012) norms reflect contemporary adult‘s Algerian spirometry. PLoS One. 2018;13(9):e0203023.
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343.
  • Cooper BG, Stocks J, Hall GL, et al. The global lung function initiative (GLI) Network: bringing the world‘s respiratory reference values together. Breathe. 2017;13(3):e56–e64.
  • Kim N, Park MH, Kim SY, et al. Discordance in spirometric interpretations based on korean and non-korean reference equations. Ann Occup Environ Med. 2013;25(1):42.
  • Talaminos Barroso A, Márquez Martín E, Roa Romero LM, et al. Factors affecting lung function: a review of the literature. Arch Bronconeumol. 2018;54:327–332.
  • Dejsomritrutai W, Chuaychoo B. Impact of GLI-2012 spirometric references and lower limit of normal on prevalence of COPD in older urban Thai persons. J Med Assoc Thai. 2016;99(3):276–281.
  • Miller MR. Choosing and using lung function prediction equations. Eur Respir J. 2016;48(6):1535–1537.
  • Huprikar NA, Holley AB, Skabelund AJ, et al. A comparison of GLI12 with NHANES III spirometry reference values: the implications in defining obstruction. Ann Am Thorac Soc. 2019;16(2):225-230.
  • Hüls A, Krämer U, Stolz S, et al. Applicability of the Global Lung Initiative 2012 reference values for spirometry for longitudinal data of elderly women. PLoS One. 2016;11(6):e0157569.
  • Arigliani M, Canciani MC, Mottini G, et al. Evaluation of the global lung initiative 2012 reference values for spirometry in African children. Am J Respir Crit Care Med. 2017;195(2):229–236.
  • Lum S, Bountziouka V, Quanjer P, et al. Challenges in collating spirometry reference data for South-Asian children: an observational study. PLoS One. 2016;11(4):e0154336.
  • Marcus BS, McAvay G, Gill TM, et al. Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons. J Am Geriatr Soc. 2015;63(2):251–257.
  • Miner B, Tinetti ME, Van Ness PH, et al. Dyspnea in community-dwelling older persons: a multifactorial geriatric health condition. J Am Geriatr Soc. 2016;64(10):2042–2050.
  • Vaz Fragoso CA, McAvay G, Van Ness PH, et al. Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med. 2015;192(7):817–825.
  • Miller MR, Thinggaard M, Christensen K, et al. Best lung function equations for the very elderly selected by survival analysis. Eur Respir J. 2014;43(5):1338–1346.
  • Hulo S, Broucker V, Giovannelli J, et al. Global lung function initiative reference equations better describe a middle-aged, healthy French population than the European Community for steel and coal. Eur Respir J. 2016;48(6):1779–1781.
  • Kainu A, Tomonen K, Toika J, et al. Reference values of spirometry for Finnish adults. Clin Physiol Func Imaging. 2016;36(5):346–358.
  • Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Eur Respir J. 2016;48(1):133–141.
  • Brazzale DJ, Hall GL, Pretto JJ. Effects of adopting the new global lung function initiative 2012 reference equations on the interpretation of spirometry. Respiration. 2013;86(3):183–189.
  • Embling LA, Zagami D, Sriram KB, et al. Sivakumaran PEffect of changing from the national health and nutritional examination survey III spirometry reference range to that of the global lung initiative 2012 at gold coast hospital and health service. J Thorac Dis. 2016;8(12):3739–3743.
  • Chaiwong W, Uthaikhup S, Liwsrisakun C, et al. Effect of changing reference equations for spirometry interpretation in Thai people. J Thorac Dis. 2019;11(1):113–122.
  • Backman H, Lindberg A, Sovijärvi A, et al. Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sample. BMC Pulm Med. 2015;15:26.
  • Turkeshi E, Vaes B, Andreeva E, et al. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults. Eur Respir J. 2015;46(1):123–132.
  • van Dijk W, Tan W, Li P, et al. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 2015;13(1):41–48.
  • Kainu A, Timonen K, Lindqvist A, et al. GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population. ERJ Open Res. 2016;2(4):pii 00084–2015.
  • Tilert T, Paulose-Ram R, Howard D, et al. Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the national health and nutrition examination survey (NHANES) 2007-2012. EC Pulmonol Respir Med. 2018;7(9):650–662.
  • Lenoir A, Fitting JW, Marques-Vidal PM, et al. GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study. Respir Res. 2018;19(1):250.
  • Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985.
  • Spero K, Bayasi G, Beaudry L, et al. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2417–2423.
  • Celli BR, Decramer M, Wedzicha JA, et al. An official American thoracic society/European respiratory society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4–e27.
  • Mattila T, Vasankari T, Kanervisto M, et al. Association between all-cause and cause-specific mortality and the GOLD stages 1-4: a 30-year follow-up among Finnish adults. Respir Med. 2015;109(8):1012–1018.
  • Torén K, Andersson M, Olin AC, et al. Airflow limitation classified with the fixed ratio or the lower limit of normal and cause-specific mortality: a prospective study. Respir Med. 2018;144:36–41.
  • Fielding S, Pijnenburg M, de Jongste JC, et al. Change in FEV1 and Feno measurements as predictors of future asthma outcomes in children. Chest. 2019;155(18):S0012–3692. 32590-X.
  • Teach SJ, Gergen PJ, Szefler SJ, et al. Seasonal risk factors for asthma exacerbations among inner-city children. J Allergy Clin Immunol. 2015;135(6):1465–1473.
  • Yu S, Park S, Park CS, et al. Association between the Ratio of FEV1 to FVC and the exposure level to air pollution in neversmoking adult refractory asthmatics using data clustered by patient in the Soonchunhyang asthma cohort database. Int J Environ Res Public Health. 2018;15(11):E2349.
  • Morgan BW, Grigsby MR, Siddharthan T, et al. Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries. J Allergy Clin Immunol. 2019;143(4):1598-1606.
  • Kurth L, Doney B, Halldin C, et al. Airflow obstruction among ever-employed U.S. adults aged 18–79 years by industry and occupation: NHANES 2007–2008 to 2011–2012. Am J Ind Med. 2019;62(1):30–42.
  • Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J. 2019;53(2):1801193.
  • Lowe KE, Make BJ, Crapo JD, et al. Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease. ERJ Open Res. 2018;4(4):00069–2018.
  • Agustí A, Noell G, Brugada J, et al. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med. 2017;5(12):935–945.
  • Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):32.
  • Lutsey PL, Chen N, Mirabelli MC, et al. Impaired lung function, lung disease and risk of incident dementia. Am J Respir Crit Care Med. [cited 2018 Nov 15]; [63 p.]. DOI:10.1164/RCCM.201807-1220OC
  • Fernandes FLA, Carvalho-Pinto RM, Stelmach R, et al. Spirometry in patients screened for coronary artery disease: is it useful? J Bras Pneumol. 2018;44(4):299–306.
  • Bambra G, Jalota L, Kapoor C, et al. Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD. Clin Respir J. 2017;11(6):805–811.
  • Hidalgo Sierra V, Hernández Mezquita MÁ, Palomo Cobos L, et al. Usefulness of the Piko-6 portable device for early COPD detection in primary care. Arch Bronconeumol. 2018;54(9):460–466.
  • Tupper OD, Gregersen TL, Ringbaek T, et al. Effect of tele-health care on quality of life in patients with severe COPD: a randomized clinical trial. Int J Chron Obstruct Pulmon Dis. 2018;13:2657–2662.
  • Watz H, Tetzlaff K, Magnussen H, et al. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res. 2018;19(1):251.
  • Schermer TR, Vatsolaki M, Behr R, et al. Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial. NPJ Prim Care Respir Med. 2018;28(1):17.
  • Silsupadol P, Teja K, Lugade V. Reliability and validity of a smartphone-based assessment of gait parameters across walking speed and smartphone locations: body, bag, belt, hand, and pocket. Gait Posture. 2017;58:516–522.
  • Joo S, Lee K, Song CA. Comparative study of smartphone game with spirometry for pulmonary function assessment in stroke patients. Biomed Res Int. [cited 2018 Nov 4]; [6 p.]. DOI:10.1155/2018/2439312
  • Viswanath V, Garrison J, Patel S. SpiroConfidence: determining the validity of smartphone based spirometry using machine learning. Conf Proc IEEE Eng Med Biol Soc. 2018;2018:5499–5502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.